During the past decade, Charles University General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charles University General Hospital" #1 sponsor was "Celgene" with 1 trials, followed by "Czech Lymphoma Study Group" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored, "Ipsen" with 1 trials sponsored and "Mayo Clinic" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charles University General Hospital" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Charles University General Hospital" are "Acromegaly" (1 trials), "Arrhythmia" (1 trials), "Atrial Fibrillation" (1 trials), "Lymphoma" (1 trials) and "Lymphoma, Mantle-Cell" (1 trials). Many other conditions were trialed in "Charles University General Hospital" in a lesser frequency.

Most popular intervention types in "Charles University General Hospital" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine Hydrochloride" (1 trials), "Lanreotide (Autogel formulation)" (1 trials), "Left atrial ablation" (1 trials), "Parsaclisib" (1 trials) and "Polatuzumab vedotin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charles University General Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Charles University General Hospital". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Charles University General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Charles University General Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".